Clinical trial
Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
NCT03762291 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 6, 2021
- Completion date
- August 5, 2024
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.